Health Condition 1: L508- Other urticaria Health Condition 2: L502- Urticaria due to cold and heat Health Condition 3: L501- Idiopathic urticaria
Conditions
Interventions
Intervention1: Homoeopathic Medicines: Dose and Potency according to susceptibility of patient and need of the case
Globule number 30
Route of drug administration Sublingual
for 3 months
Control
Sponsors
swasthya kalyan Homoeopathic Medical College And Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed cases of chronic urticaria, based on EAACI/GA LEN/EDF/WAO consensus guidelines or ICD-11 clinical guidance including both chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU) presenting with recurrent wheals angioedema or both persisting for six weeks or more. Patients aged 18 and above. Both the sexes. Patients willing to participate and provide written informed consent.
Exclusion criteria
Exclusion criteria: Patients unable or unwilling to provide written informed consent. Patients with other medical conditions or those receiving systemic corticosteroids immunosuppressive therapy or alternative treatments that could affect the outcome of the study will be excluded. Patients with other dermatological or systemic conditions that can mimic chronic urticaria such as urticarial vasculitis bullous pemphigoid mastocytosis (e.g. urticaria pigmentosa) cutaneous lupus erythematosus papular urticaria drug-induced dermatoses or napkin-area infection Schnitzler s Syndrome Gleich s Syndrome or Well s Syndrome (e.g. Eosinophilic Cellulitis). Patients with systemic autoinflammatory disorders such as Cryopyrin-Associated Periodic Syndromes (CAPS) including Familial Cold Autoinflammatory Syndrome (FCAS) Muckle-Wells Syndrome (MWS) and Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At the end of the study, it is expected that individualized Homoeopathic medicine will play an effective role in the treatment of chronic urticaria, as measured by the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). It is expected that analysis of the study data will identify the most commonly prescribed Homoeopathic medicine in cases of chronic urticaria. Timepoint: At Baseline and after 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Jagdish Thebar
swasthya kalyan homeopathic medical college jaipur
Outcome results
None listed